(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 1,553.08%414.81K | 1,121.59%413.92K | 99.62%37.57K | -25.68%122.33K | 42.42%44.54K | 17.20%25.09K | -59.72%33.88K | -32.32%18.82K | 458.43%164.61K | 30.10%31.27K |
Selling and administrative expenses | 1,132.18%262.2K | 647.29%204.15K | 89.82%33.67K | -25.68%122.33K | 79.07%56K | -0.61%21.28K | -61.41%27.32K | -36.22%17.74K | 458.43%164.61K | 30.10%31.27K |
-General and administrative expense | 1,132.18%262.2K | 647.29%204.15K | 89.82%33.67K | -25.68%122.33K | 79.07%56K | -0.61%21.28K | -61.41%27.32K | -36.22%17.74K | 458.43%164.61K | 30.10%31.27K |
Other operating expenses | 3,901.36%152.61K | 3,095.28%209.77K | 260.11%3.9K | ---- | ---- | --3.81K | -50.74%6.57K | --1.08K | ---- | ---- |
Operating profit | -1,553.08%-414.81K | -1,121.59%-413.92K | -99.62%-37.57K | 25.68%-122.33K | -42.42%-44.54K | -17.20%-25.09K | 59.72%-33.88K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Net non-operating interest income (expenses) | 12.07K | 370 | 0 | 0 | ||||||
Non-operating interest income | --12.07K | ---- | --370 | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
Other net income (expenses) | -25.91K | 106.08%12.25K | 394 | -201.64K | -216 | -201.42K | ||||
Gain on sale of security | ---11.78K | --12.25K | --394 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special income (charges) | ---14.12K | --0 | ---- | ---201.64K | ---216 | --0 | ---201.42K | ---- | --0 | --0 |
-Less:Impairment of capital assets | --14.12K | --0 | ---- | --201.64K | --216 | --0 | --201.42K | ---- | --0 | --0 |
Income before tax | -1,608.23%-428.65K | -70.70%-401.68K | -95.56%-36.8K | -96.81%-323.97K | -43.11%-44.75K | -17.20%-25.09K | -179.72%-235.31K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -1,608.23%-428.65K | -70.70%-401.68K | -95.56%-36.8K | -96.81%-323.97K | -43.11%-44.75K | -17.20%-25.09K | -179.72%-235.31K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Net income continuous operations | -1,608.23%-428.65K | -70.70%-401.68K | -95.56%-36.8K | -96.81%-323.97K | -43.11%-44.75K | -17.20%-25.09K | -179.72%-235.31K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -1,608.23%-428.65K | -70.70%-401.68K | -95.56%-36.8K | -96.81%-323.97K | -43.11%-44.75K | -17.20%-25.09K | -179.72%-235.31K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -1,608.23%-428.65K | -70.70%-401.68K | -95.56%-36.8K | -96.81%-323.97K | -43.11%-44.75K | -17.20%-25.09K | -179.72%-235.31K | 32.32%-18.82K | -458.43%-164.61K | -30.10%-31.27K |
Diluted earnings per share | -375.74%-0.01 | 50.00%-0.01 | -75.70%-0.0029 | -200.00%-0.03 | -0.01 | -15.12%-0.0021 | -100.00%-0.02 | 30.30%-0.0017 | -292.62%-0.01 | 0 |
Basic earnings per share | -375.74%-0.01 | 50.00%-0.01 | -75.70%-0.0029 | -200.00%-0.03 | -0.01 | -15.12%-0.0021 | -100.00%-0.02 | 30.30%-0.0017 | -292.62%-0.01 | 0 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.